Action Alert: Support SB 360 – Lower Prescription Drug Costs for Kansas Patients
Urge Your Kansas Senator to Vote YES on SB 360!
The Association of Women in Rheumatology (AWIR) needs your help! Senate Bill 360, the Kansas Consumer Prescription Protection and Accountability Act, is critical legislation that would improve transparency in the prescription drug system and ensure patients directly benefit from prescription drug rebates. This bill is especially important for Kansans living with chronic and autoimmune conditions who rely on long-term, often costly medications.
AWIR urges you to contact your Kansas Senator and ask them to support SB 360.
What’s at Stake?
Patients with chronic conditions—such as rheumatoid arthritis, lupus, and other autoimmune diseases—often require specialty or branded medications to manage their health and prevent disease progression. While Pharmacy Benefit Managers (PBMs) negotiate large rebates with drug manufacturers, those savings are rarely passed on to patients at the pharmacy counter.
Instead, patients are charged cost-sharing based on inflated list prices, leaving many unable to afford the medications their physicians prescribe. As a result, patients may delay treatment, ration doses, or abandon therapy altogether—leading to worse health outcomes and higher overall health care costs.
Why Is SB 360 Important?
Take Action Now!
It takes just a few minutes to make your voice heard. Use our pre-drafted letter to contact your Kansas Senator and urge them to vote YES on SB 360. We strongly encourage you to personalize the message and share how prescription drug costs affect you or your patients.
Thank you for standing up for patients living with chronic and rheumatic diseases. Together, we can help ensure Kansans can afford the medications they need—when they need them.